Using Levetiracetam for < 1 year may adversely affect the lumbar spine. No difference in femur bone scores between patients on LEV for < 1 year and > 5 years. ... |
The currently available data do not support a negative association between levetiracetam and bone health. Two studies suggest there may be an effect on bone ... |
Various studies have indicated a loss of bone density and increased risk of fractures in people using long-term anti-epileptic drugs. |
Highlights · Levetiracetam will not result in a decrease in the bone mineral density of the femoral neck and lumbar spine in patients with epilepsy. |
Many studies have shown a significant reduction in bone mineral density (BMD) and an increased fracture risk in patients treated with enzyme-inducing ... |
Do all anti-epileptic drugs cause osteoporosis and increase fracture risk? Various studies have indicated a loss of bone density and increased risk of fractures ... |
Many studies have shown an association between antiseizure medications and osteoporosis, particularly with older medications such as phenytoin (Dilantin), ... |
9 февр. 2023 г. · Both epilepsy and ASMs are associated with adverse effects on bone health. Persons with epilepsy treated with ASMs have increased rates of bone ... |
The results of systematic evaluation showed that the treatment of new antiseizure medication was related to the decrease of bone mineral density. In addition, ... Introduction · Materials and methods · Results · Discussion |
6 янв. 2012 г. · Levetiracetam had effects on bone mineral density and markers of bone turnover that were similar to those seen with the older antiepileptic drugs carbamazepine ... |
Novbeti > |
Axtarisha Qayit Anarim.Az Anarim.Az Sayt Rehberliyi ile Elaqe Saytdan Istifade Qaydalari Anarim.Az 2004-2023 |